TY  - CONF

T1  - Patients with bone metastases from solid tumours and poor prognostic features may gain survival benefits from zoledronic acid

JO  - BONE

PY  - 2011/01/01

AU  - Body J

AU  - Cook R

AU  - Costa L

AU  - Brown J

AU  - Terpos E

AU  - Saad F

AU  - Lipton A

AU  - Coleman R

ED  - 

DO  - DOI: 10.1016/j.bone.2010.10.052

VL  - 48

IS  - 1

SP  - S20

EP  - S21

Y2  - 2024/12/22

ER  -